사람면역결핍바이러스 감염과 장내세균총: 면역 활성화와 대사 질환과 연관된 마이크로바이옴 연구 고찰
Human Immunodeficiency Virus Infection and Gut Microbiota: A Review on Gut Microbiome Associated with Immune Activation and Metabolic Diseases
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
This review provides the complex interaction between human immunodeficiency virus (HIV) infection and gut microbiota. HIV infection exerts chronic effects by impairing the immune system, closely linked with alterations in gut microbiota. While advances in highly active antiretroviral therapy have achieved HIV undetectable in the bloodstream, persistent microbial translocation in the gut microbiota despite antiviral treatment leads to systemic immune activation and chronic inflammation in people living with HIV (PLHIV). There is the need for elucidating which specific microbes and their byproducts that contribute to immune activation and chronic inflammation in PLHIV. Furthermore, gaining a deeper understanding of the connection between HIV infection and metabolic disorders holds significant potential for addressing and managing conditions like premature aging and metabolic diseases. Monitoring alterations in gut microbiota composition shows promise in developing diagnostic markers and therapeutic potential for metabolic disorders in PLHIV.
Abstract
This review provides the complex interaction between human immunodeficiency virus (HIV) infection and gut microbiota. HIV infection exerts chronic effects by impairing the immune system, closely linked with alterations in gut microbiota. While advances in highly active antiretroviral therapy have achieved HIV undetectable in the bloodstream, persistent microbial translocation in the gut microbiota despite antiviral treatment leads to systemic immune activation and chronic inflammation in people living with HIV (PLHIV). There is the need for elucidating which specific microbes and their byproducts that contribute to immune activation and chronic inflammation in PLHIV. Furthermore, gaining a deeper understanding of the connection between HIV infection and metabolic disorders holds significant potential for addressing and managing conditions like premature aging and metabolic diseases. Monitoring alterations in gut microbiota composition shows promise in developing diagnostic markers and therapeutic potential for metabolic disorders in PLHIV.
참고문헌 (16)
- Agus A, "Gut microbiota-derived metabolites as central regulators in metabolic disorders", Gut, 70, pp.1174~1182 (2021)
- Bourgi K, "Inflammation and metabolic complications in HIV", Curr HIV, 2018, pp.15, 371~381
- Kim HN, "Reversion of gut microbiota during the recovery phase in patients with asymptomatic or mild COVID-19 : longitudinal study", Microorganisms, 9, pp.1237~ (2021)
- Park SK, "Detection of SARS-CoV-2in fecal samples from patients with asymptomatic and mild COVID-19 in Korea", Clin Gastroenterol Hepatol, 19, pp.1387~1394 (2021)
- Rocafort M, "Evolution of the gut microbiome following acute HIV-1 infection", Microbiome, 7, pp.73~ (2019)
- Lagathu C, "Basic science and pathogenesis of ageing with HIV : potential mechanisms and biomarkers", AIDS, 31(Suppl 2), pp.S105~S119 (2017)
- De Francesco D, "Do people living with HIV experience greater age advancement than their HIV-negative counterparts?", AIDS, 33, pp.259~268 (2019)
- Rodríguez-Centeno J, "Effects of tenofovir on telomeres, telomerase and T cell maturational subset distribution in long-term aviraemic HIV-infected adults", J Antimicrob Chemother, 77, pp.1125~1132 (2022)
- Schank M, "The impact of HIV-and ART-induced mitochondrial dysfunction in cellular senescence and aging", Cells, 10, pp.174~ (2021)
- Tincati C, "Biomarkers of aging in HIV : inflammation and the microbiome", Eur Geriatr Med, 10, pp.175~182 (2019)
- Han WM, "Non-alcoholic fatty liver disease and non-alcoholic steatohepatitis with liver fibrosis as predictors of new-onset diabetes mellitus in people living with HIV : a longitudinal cohort study", Clin Infect Dis (2023)[DOI]
- Park Sunghee, "The Role of Age in Subclinical Atherosclerosis in Asian People Living with Human Immunodeficiency Virus", Infection and Chemotherapy, 54(2), pp.308~315 (2022), 대한감염학회[DOI]
- Kim HN, "Gut microbiota and risk of persistent nonalcoholic fatty liver diseases", J Clin Med, 8, pp.1089~ (2019)
- Joo EJ, "Relationship between gut microbiome diversity and hepatitis B viral load in patients with chronic hepatitis B", Gut Pathog, 13, pp.65~ (2021)
- Li SX, "Complexities of gut microbiome dysbiosis in the context of HIV infection and antiretroviral therapy", Clin Pharmacol Ther, 99, pp.600~611 (2016)
- Vujkovic-Cvijin I, "HIV-associated gut dysbiosis is independent of sexual practice and correlates with noncommunicable diseases", Nat Commun, 11, pp.2448~ (2020)